News Briefs: Elevance’s Deal to Buy Louisiana Blues Hits Roadblocks

The $2.5 billion deal between Elevance Health, Inc. and Blue Cross and Blue Shield of Louisiana is facing some hiccups, per the New Orleans Times-Picayune. The Louisiana Blues affiliate must reissue ballots to 92,000 policyholders that will allow them to approve or reject the sale and invalidate proxy ballots that it’s already received. The insurer will also reschedule a meeting and official vote until after the state’s Dept. of Insurance has held a two-day hearing on the proposed sale. Louisiana Insurance Commissioner Jim Donelon and Attorney General and gubernatorial frontrunner Jeff Landry — both Republicans — have been critical of the deal, the Times-Picayune reported. The newspaper also said that attorneys in the state Dept. of Insurance “fully expect litigation” over the proposed transaction, which Elevance announced in January.

0 Comments
© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

cms-website
February 23

Panelists: CMS Prior Authorization Rule Should Help, But More Is Needed

READ MORE
blue-cross-blue-shield-image
February 23

Checking on the Blues: Analysts Predict Margin Uptick in ’23 Will Be Short-Lived

READ MORE
techy-illustration
February 23

ONC Head Touts Interoperability Wins, Poses AI Questions

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today